Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05651607Phase 2Completed

Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa

Role: collaborator

NCT05019807Not ApplicableCompleted

Comparing the Compliance to Follow-up in Patients With Diabetic Macular Edema

Role: lead

NCT04544553Not ApplicableCompleted

Barriers to Eye Screening for People With Diabetes in India

Role: lead

NCT01783743Not ApplicableCompleted

Identification of TT Cases by Community Treatment Assistants: An Assessment

Role: collaborator

NCT01949454Not ApplicableCompleted

Fluorometholone as Ancillary Therapy for TT Surgery

Role: collaborator

All 5 trials loaded